Performance Evaluation of Host Biomarker Combinations for the Diagnosis of Serious Bacterial Infection in Young

Aurélie Portefaix1,2, Sylvie Pons3,4, Antoine Ouziel5

  • 1Clinical Investigation Center (CIC 1407), Hospices Civils de Lyon, 69677 Bron, France.

Insights

Identifying new protein marker combinations can help diagnose serious bacterial infections (SBI) in febrile children. While some combinations showed promise, further optimization is needed for accurate diagnosis in young children.

Area of Science:

  • Pediatric Infectious Diseases
  • Biomarker Discovery
  • Computational Biology

Background:

  • Diagnosing serious bacterial infections (SBI) in young febrile children is complex.
  • Current diagnostic methods require improvement for accurate differentiation between bacterial and viral infections.

Purpose of the Study:

  • To identify novel protein marker combinations for differentiating bacterial from viral infections in young children.
  • To evaluate the diagnostic performance of these combinations against established biomarkers like CRP and PCT.

Main Methods:

  • Prospective, multicentre observational study involving 983 children (7 days-36 months) with suspected SBI.
  • Measurement of seven protein markers (CRP, PCT, IL-6, NGAL, MxA, TRAIL, IP-10) in blood.
  • Application of computational modeling with independent training and validation cohorts to assess marker combinations.

Main Results:

  • Several protein marker combinations showed potential to outperform CRP and PCT individually.
  • No combination met the targeted performance criteria (LR+ ≥ 5.67, LR- ≤ 0.5) in the overall 7-36 month population.
  • The CRP/MxA/TRAIL combination demonstrated promising performance in younger infants (7-91 days old) with AUC 0.895, LR+ 10.46, LR- 0.16.

Conclusions:

  • Computational modeling of protein marker combinations is a promising approach for SBI diagnosis.
  • Further optimization is required to enhance the diagnostic accuracy of these models in young febrile children.
  • The CRP/MxA/TRAIL combination shows potential for improved diagnosis in a specific subgroup of very young infants.